End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-15 pm EDT
|
5-day change
|
1st Jan Change
|
40.14
CNY
|
-6.52%
|
|
-3.96%
|
+29.01%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,160
|
7,131
|
8,830
|
10,537
|
13,595
|
-
|
-
|
Enterprise Value (EV)
1 |
6,160
|
7,131
|
8,830
|
10,537
|
13,595
|
13,595
|
13,595
|
P/E ratio
|
16.1
x
|
26.8
x
|
11.4
x
|
7.59
x
|
7.14
x
|
5.78
x
|
4.69
x
|
Yield
|
-
|
-
|
3.84%
|
4.82%
|
3.51%
|
4.3%
|
4.95%
|
Capitalization / Revenue
|
-
|
6.54
x
|
5
x
|
4.39
x
|
4.11
x
|
3.2
x
|
2.6
x
|
EV / Revenue
|
-
|
6.54
x
|
5
x
|
4.39
x
|
4.11
x
|
3.2
x
|
2.6
x
|
EV / EBITDA
|
-
|
29.7
x
|
16.1
x
|
10.8
x
|
10.9
x
|
8.87
x
|
7.32
x
|
EV / FCF
|
-
|
-
|
337
x
|
72.6
x
|
25
x
|
15.5
x
|
11.6
x
|
FCF Yield
|
-
|
-
|
0.3%
|
1.38%
|
4%
|
6.47%
|
8.61%
|
Price to Book
|
-
|
2.24
x
|
2.27
x
|
2.08
x
|
1.99
x
|
1.57
x
|
1.19
x
|
Nbr of stocks (in thousands)
|
338,640
|
338,640
|
338,640
|
338,640
|
338,678
|
-
|
-
|
Reference price
2 |
18.19
|
21.06
|
26.08
|
31.12
|
40.14
|
40.14
|
40.14
|
Announcement Date
|
4/16/21
|
4/22/22
|
4/19/23
|
4/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,090
|
1,765
|
2,400
|
3,306
|
4,255
|
5,224
|
EBITDA
1 |
-
|
240.2
|
549.9
|
974.1
|
1,249
|
1,532
|
1,857
|
EBIT
1 |
-
|
156.9
|
463.7
|
871
|
1,125
|
1,397
|
1,714
|
Operating Margin
|
-
|
14.39%
|
26.27%
|
36.29%
|
34.04%
|
32.84%
|
32.82%
|
Earnings before Tax (EBT)
1 |
-
|
154.8
|
461.4
|
866.3
|
1,123
|
1,395
|
1,712
|
Net income
1 |
163.5
|
132.9
|
388.1
|
733.6
|
952.5
|
1,175
|
1,451
|
Net margin
|
-
|
12.18%
|
21.99%
|
30.57%
|
28.82%
|
27.63%
|
27.77%
|
EPS
2 |
1.130
|
0.7847
|
2.292
|
4.098
|
5.624
|
6.941
|
8.567
|
Free Cash Flow
1 |
-
|
-
|
26.23
|
145.1
|
544
|
879
|
1,170
|
FCF margin
|
-
|
-
|
1.49%
|
6.05%
|
16.46%
|
20.66%
|
22.4%
|
FCF Conversion (EBITDA)
|
-
|
-
|
4.77%
|
14.9%
|
43.56%
|
57.37%
|
63.01%
|
FCF Conversion (Net income)
|
-
|
-
|
6.76%
|
19.79%
|
57.11%
|
74.78%
|
80.65%
|
Dividend per Share
2 |
-
|
-
|
1.000
|
1.500
|
1.408
|
1.728
|
1.985
|
Announcement Date
|
4/16/21
|
4/22/22
|
4/19/23
|
4/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
2023 S1
|
---|
Net sales
1 |
-
|
602.5
|
1,190
|
EBITDA
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
Net income
1 |
160.2
|
190.3
|
350.5
|
Net margin
|
-
|
31.59%
|
29.45%
|
EPS
|
0.9463
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
4/25/23
|
8/17/23
|
8/17/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
26.2
|
145
|
544
|
879
|
1,170
|
ROE (net income / shareholders' equity)
|
-
|
8.68%
|
22%
|
32.2%
|
28.8%
|
28.1%
|
26.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
19.5%
|
20.6%
|
20.1%
|
Assets
1 |
-
|
-
|
-
|
-
|
4,889
|
5,694
|
7,233
|
Book Value Per Share
2 |
-
|
9.390
|
11.50
|
15.00
|
20.20
|
25.60
|
33.60
|
Cash Flow per Share
2 |
-
|
0.9000
|
1.700
|
4.720
|
3.470
|
7.040
|
6.680
|
Capex
1 |
-
|
209
|
261
|
654
|
369
|
379
|
352
|
Capex / Sales
|
-
|
19.21%
|
14.79%
|
27.24%
|
11.17%
|
8.91%
|
6.75%
|
Announcement Date
|
4/16/21
|
4/22/22
|
4/19/23
|
4/16/24
|
-
|
-
|
-
|
Last Close Price
40.14
CNY Average target price
105.1
CNY Spread / Average Target +161.92% Consensus |
1st Jan change
|
Capi.
|
---|
| +29.01% | 2.01B | | +17.29% | 66.52B | | +2.81% | 50.34B | | +17.88% | 42.01B | | +19.53% | 26.68B | | +11.82% | 19.97B | | +0.19% | 17.32B | | -21.87% | 15.7B | | +0.91% | 15.53B | | -10.58% | 14.99B |
Other Specialty Chemicals
|